Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about NYSE:NVO
Recent news which mentions NYSE:NVO
< Previous
1
2
3
4
Next >
3 Pharmaceutical Stocks Betting Big on Weight Loss Drugs
February 25, 2025
Tags
NYSE:NVO
NYSE:LLY
NASDAQ:AMGN
From
StockNews.com
3 European Stocks to Buy as the Region Recovers
October 16, 2024
Tags
NYSE:NVO
NYSE:SAP
:WKME
From
StockNews.com
3 European Stocks to Buy as the Continent’s Economy Recovers
September 17, 2024
Tags
NYSE:NVS
:WKME
NYSE:NVO
From
StockNews.com
With Obesity Drug Demand Surging, Is Novo Nordisk a Buy?
September 12, 2024
Tags
NYSE:ABBV
NYSE:GSK
NYSE:MRK
From
StockNews.com
NVO Stock Alert: Why Is Novo Nordisk Down 8% Today?
August 07, 2024
Tickers
NVO
Tags
NYSE:NVO
NVO
Today's Market
From
InvestorPlace
NVO Stock Earnings: Novo Nordisk Misses EPS, Misses Revenue for Q2 2024
August 07, 2024
Tickers
NVO
Tags
NVO
NYSE:NVO
Earnings Reports
From
InvestorPlace
Will Novo Nordisk's (NVO) Q2 Earnings Reflect Its Market Potential?
July 10, 2024
Tickers
NVO
Tags
NYSE:NVS
NYSE:AZN
NYSE:MRK
From
StockNews.com
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development
June 11, 2024
Tickers
AZN
CRDL
NVO
SNY
Tags
NASDAQ:CRDL
NYSE:NVO
NASDAQ:SNY
From
News Direct
Eli Lilly (LLY) vs. Novo Nordisk (NVO): Which Pharma Stock Is Driving Long-Term 2024 Profits?
May 23, 2024
Tickers
LLY
NVO
Tags
NYSE:LLY
NYSE:NVO
From
StockNews.com
NVO Stock Earnings: Novo Nordisk Beats EPS, Beats Revenue for Q1 2024
May 02, 2024
Tickers
NVO
Tags
Market News
Earnings Reports
NYSE:NVO
From
InvestorPlace
3 Popular Pharma Stocks Worth Buying Now
May 01, 2024
Tags
NYSE:NVO
NYSE:GSK
NASDAQ:COLL
From
StockNews.com
4 Pharma Giants Sparking Investor Interest
April 09, 2024
Tags
NYSE:NVO
NYSE:JNJ
:hARP
From
StockNews.com
4 Pharma Giants Sparking Investor Interest
April 09, 2024
Tags
NYSE:NVO
NYSE:JNJ
NYSE:MRK
From
StockNews.com
Canopy Growth (CGC) vs. Novo Nordisk (NVO): Which Pharma Stock Is a Better Investment?
April 05, 2024
Tickers
CGC
NVO
Tags
:CGC
NYSE:NVO
From
StockNews.com
Zoetis (ZTS): Analyzing Earnings for Potential Gains
February 12, 2024
Tickers
ZTS
Tags
NYSE:GSK
NYSE:ABBV
NYSE:NVO
From
StockNews.com
Eli Lilly & Co. (LLY) Pre-Earnings Moves: Buy or Watch?
February 05, 2024
Tickers
LLY
Tags
NYSE:NVS
NYSE:NVO
NYSE:TARO
From
StockNews.com
Analyzing 3 Biotech Stocks for 2024 Gain Potential
February 05, 2024
Tags
NYSE:NVO
NASDAQ:VRTX
NASDAQ:ALKS
From
StockNews.com
AbbVie (ABBV) Earnings Preview: Buy or Sell Opportunities
February 01, 2024
Tickers
ABBV
Tags
NYSE:NVO
NYSE:TARO
NYSE:NVS
From
StockNews.com
Pharma Stock Analysis: Buy, Hold, or Sell These 4?
January 31, 2024
Tags
NASDAQ:MDGL
NYSE:PFE
NYSE:NVO
From
StockNews.com
Merck (MRK): Quarterly Earnings - What Investors Should Know
January 31, 2024
Tickers
MRK
Tags
NYSE:NVS
NYSE:MRK
NYSE:TARO
From
StockNews.com
Pfizer (PFE): Pre-Earnings Strategies
January 29, 2024
Tickers
PFE
Tags
NYSE:PFE
NYSE:NVS
:SNPHY
From
StockNews.com
Johnson & Johnson (JNJ): Analyzing Signals Before Quarterly Earnings
January 22, 2024
Tickers
JNJ
Tags
:AMAM
:SNPHY
NYSE:NVO
From
StockNews.com
3 Pharma Stocks for January 2024 Profits
January 16, 2024
Tags
NASDAQ:PCRX
:ETON
:OMGA
From
StockNews.com
Tilray Brands (TLRY) Earnings Spotlight -- Buy or Sell?
January 12, 2024
Tickers
TLRY
Tags
NYSE:BMY
NYSE:NVO
:TLRY
From
StockNews.com
3 Top-Rated Pharma Stocks Worth Including in Your November Portfolio
November 02, 2023
Tags
NYSE:RDY
NYSE:ABBV
NYSE:NVO
From
StockNews.com
3 Pharma Stocks With Market Impact to Consider Buying
October 26, 2023
Tags
NASDAQ:AMRX
NYSE:RDY
NYSE:NVO
From
StockNews.com
Should You Invest in Johnson & Johnson (JNJ) Following Q3 Results
October 24, 2023
Tickers
JNJ
Tags
NYSE:NVO
NYSE:ABBV
NYSE:NVS
From
StockNews.com
Is Tilray Brands (TLRY) a Possible Buy Opportunity Before Earnings?
October 03, 2023
Tickers
TLRY
Tags
NYSE:NVS
NYSE:NVO
:TLRY
From
StockNews.com
3 A-Rated Pharma Buys for October
September 28, 2023
Tags
NYSE:AZN
NASDAQ:NBIX
NYSE:NVO
From
StockNews.com
Pfizer Inc. (PFE) – Buy or Hold Analysis on This Pharma Stock
September 22, 2023
Tickers
PFE
Tags
NYSE:NVS
NYSE:PFE
NYSE:NVO
From
StockNews.com
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.